Passage Bio, Inc.
PASG
$7.35
-$0.29-3.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.88M | 19.67M | 22.57M | 24.56M | 24.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.15M | 47.08M | 54.33M | 60.94M | 65.17M |
| Operating Income | -43.15M | -47.08M | -54.33M | -60.94M | -65.17M |
| Income Before Tax | -45.52M | -45.26M | -56.86M | -63.46M | -64.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.52 | -45.26 | -56.86 | -63.46 | -64.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.52M | -45.26M | -56.86M | -63.46M | -64.77M |
| EBIT | -43.15M | -47.08M | -54.33M | -60.94M | -65.17M |
| EBITDA | -42.42M | -45.81M | -52.49M | -58.46M | -62.09M |
| EPS Basic | -14.44 | -14.40 | -18.11 | -20.23 | -21.21 |
| Normalized Basic EPS | -7.81 | -8.47 | -9.83 | -11.08 | -12.22 |
| EPS Diluted | -14.44 | -14.40 | -18.11 | -20.23 | -21.21 |
| Normalized Diluted EPS | -7.81 | -8.47 | -9.83 | -11.08 | -12.22 |
| Average Basic Shares Outstanding | 12.63M | 12.60M | 12.57M | 12.55M | 12.26M |
| Average Diluted Shares Outstanding | 12.63M | 12.60M | 12.57M | 12.55M | 12.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |